$2.46T
Total marketcap
$194.87B
Total volume
BTC 50.25%     ETH 15.68%
Dominance

Arvinas ARVN Stock

42.6 USD {{ price }} -5.016723% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
2.9B USD
LOW - HIGH [24H]
42.42 - 44.97 USD
VOLUME [24H]
786.99K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-6.62 USD

Arvinas Price Chart

Arvinas ARVN Financial and Trading Overview

Arvinas stock price 42.6 USD
Previous Close 29.4 USD
Open 29.04 USD
Bid 0 USD x 900
Ask 0 USD x 800
Day's Range 28.38 - 30.65 USD
52 Week Range 21.21 - 58.58 USD
Volume 466.76K USD
Avg. Volume 467.94K USD
Market Cap 1.62B USD
Beta (5Y Monthly) 1.758609
PE Ratio (TTM) N/A
EPS (TTM) -6.62 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 71.1 USD

ARVN Valuation Measures

Enterprise Value 501.07M USD
Trailing P/E N/A
Forward P/E -3.9186049
PEG Ratio (5 yr expected) 0.17
Price/Sales (ttm) 11.787289
Price/Book (mrq) 3.16961
Enterprise Value/Revenue 3.647
Enterprise Value/EBITDA -1.745

Trading Information

Arvinas Stock Price History

Beta (5Y Monthly) 1.758609
52-Week Change -20.91%
S&P500 52-Week Change 20.43%
52 Week High 58.58 USD
52 Week Low 21.21 USD
50-Day Moving Average 25.38 USD
200-Day Moving Average 34.89 USD

ARVN Share Statistics

Avg. Volume (3 month) 467.94K USD
Avg. Daily Volume (10-Days) 648.01K USD
Shares Outstanding 53.4M
Float 44.02M
Short Ratio 8.21
% Held by Insiders 9.52%
% Held by Institutions 96.50%
Shares Short 3.35M
Short % of Float 7.23%
Short % of Shares Outstanding 6.27%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -219.067%
Operating Margin (ttm) -213.39%
Gross Margin 100.00%
EBITDA Margin -209.025%

Management Effectiveness

Return on Assets (ttm) -13.75%
Return on Equity (ttm) -48.77%

Income Statement

Revenue (ttm) 137.4M USD
Revenue Per Share (ttm) 2.58 USD
Quarterly Revenue Growth (yoy) 22.60%
Gross Profit (ttm) 131.4M USD
EBITDA -287200000 USD
Net Income Avi to Common (ttm) -301000000 USD
Diluted EPS (ttm) -5.96
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.12B USD
Total Cash Per Share (mrq) 21.04 USD
Total Debt (mrq) 5M USD
Total Debt/Equity (mrq) 0.98 USD
Current Ratio (mrq) 4.059
Book Value Per Share (mrq) 9.569

Cash Flow Statement

Operating Cash Flow (ttm) -307600000 USD
Levered Free Cash Flow (ttm) -53950000 USD

Profile of Arvinas

Country United States
State CT
City New Haven
Address 5 Science Park
ZIP 06511
Phone 203 535 1456
Website https://www.arvinas.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 415

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 1/2 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut.

Q&A For Arvinas Stock

What is a current ARVN stock price?

Arvinas ARVN stock price today per share is 42.6 USD.

How to purchase Arvinas stock?

You can buy ARVN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Arvinas?

The stock symbol or ticker of Arvinas is ARVN.

Which industry does the Arvinas company belong to?

The Arvinas industry is Biotechnology.

How many shares does Arvinas have in circulation?

The max supply of Arvinas shares is 68.08M.

What is Arvinas Price to Earnings Ratio (PE Ratio)?

Arvinas PE Ratio is now.

What was Arvinas earnings per share over the trailing 12 months (TTM)?

Arvinas EPS is -6.62 USD over the trailing 12 months.

Which sector does the Arvinas company belong to?

The Arvinas sector is Healthcare.

Arvinas ARVN included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2568.29 USD
+0.16
2566.7 USD 2581.47 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD